Page last updated: 2024-11-01

5-nitro-2-(3-phenylpropylamino)benzoic acid and Goiter

5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Goiter in 1 studies

5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist

Goiter: Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dossena, S1
Vezzoli, V1
Cerutti, N1
Bazzini, C1
Tosco, M1
Sironi, C1
Rodighiero, S1
Meyer, G1
Fascio, U1
Fürst, J1
Ritter, M1
Fugazzola, L1
Persani, L1
Zorowka, P1
Storelli, C1
Beck-Peccoz, P1
Bottà, G1
Paulmichl, M1

Other Studies

1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Goiter

ArticleYear
Functional characterization of wild-type and a mutated form of SLC26A4 identified in a patient with Pendred syndrome.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2006, Volume: 17, Issue:5-6

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Biological Transport; Cells, Cultured; Chlorides;

2006